Virtual Science AI introduces new advisory platform

Virtual Science AI has announced the introduction of its Virtual Advisory Artificial Intelligence (AI) engagement platform. The purpose of the platform is to provide a first-of-its-kind system for the healthcare sector, as it aggregates all interactive data from advisory boards, while delivering AI-focused analytics on critical themes, topics and trends in life sciences. As an international provider of virtual advisory boards services in the pharmaceuticals industry, Virtual Science AI aims to improve critical decision-making at different stages of the product life cycle to help bring solutions to patients. It uses this approach while promoting a better understanding of how life sciences teams work with stakeholders to produce meaningful results and outcomes. The organisation uses its AI models and its virtual platform to improve stakeholder engagement in medical affairs, public affairs, R&D and functionality in commercial life sciences.